Gapping up
In reaction to strong earnings/guidance: AEHR +7.4%, COST +1.9%, MKC +1.8%
M&A news:
In reaction to strong earnings/guidance: AEHR +7.4%, COST +1.9%, MKC +1.8%
M&A news:
- NXPI +3% (Hearing Jefferies out premarket suggesting co could garner $136-172 per share in a takeout)
- NVFY +1.2% (to sell NOVA BVI and its subsidiaries for $8.5 mln to Kuka Design)
Select metals/mining stocks trading higher: AU +1.7%, GOLD +1.6%, AUY +1.6%, SSRI +1.5%, SLV +1.3%
Other news:
Other news:
- AUPH +14.8% (announces that voclosporin achieves primary and all pre-specified secondary endpoints in Phase IIb AURA-LV study for Lupus Nephritis )
- MENT +5.3% ( Elliot Mgmt discloses 8.1% active stake -- has communicated with management and Board about a broad range of operational and strategic matters)
- OZM +5.1% (confirms reaching settlements w/ the DOJ and the SEC; will pay a total penalty of $412 mln; entered into a securities purchase agreement with certain executive managing directors)
- CEMP +4.3% (light volume - announces interim results showing anti-NASH effects in the first six nonalcoholic steatohepatitis patients dosed with solithromycin in a Phase 2 study)
- CATB +3.5% (Deerfield Mgmt (James Flynn) increases passive stake)
- AA +2% (approves proposed separation; separation is scheduled to become effective before the opening of the market on November 1, 2016)
- IBN +2% (rebounding from yesterday's selloff)
- HLIT +1.2% (Comcast confirms 6.6% passive stake -- the cos entered into a warrant agreement this week)
Analyst comments:
- ECA +2.5% (upgraded to Buy from Neutral at Citigroup)
- SKX +2.2% (upgraded to Positive from Neutral at Susquehanna)
- WMT +1% (initiated with a Overweight at KeyBanc Capital Mkts)
- NKTR +0.9% (resumed with a Buy at Brean Capital)